bright nights community forum
DESCRIPTION
TRANSCRIPT
Bright Nights Bright Nights Community ForumCommunity Forum
Bipolar DisordersBipolar Disorders
University of Michigan Depression University of Michigan Depression CenterCenter
Ann Arbor Public LibraryAnn Arbor Public Library
Bright Nights ForumsBright Nights Forums
U-M Depression Center and Ann Arbor U-M Depression Center and Ann Arbor Public LibraryPublic Library Presentation on topics of interest relevant to Presentation on topics of interest relevant to
mental health in communitymental health in community Panel of experts from U-M Depression Center Panel of experts from U-M Depression Center
and Professionals in communityand Professionals in community Q/A formatQ/A format
Improve community awareness of resources Improve community awareness of resources available.available.
Bright Nights ForumsBright Nights Forums
Bipolar Disorder: March 29th Bipolar Disorder: March 29th
Suicide: May 24thSuicide: May 24th
Sleep and Depression: October 2006Sleep and Depression: October 2006
Aretaeus of CappadociaAretaeus of Cappadocia Melancholia & maniaMelancholia & mania
2 forms of the same 2 forms of the same diseasedisease
Mania manifests as Mania manifests as euphoria, but others euphoria, but others display furious ragesdisplay furious rages
Melancholics – possible Melancholics – possible for them to fly into rage..for them to fly into rage..
First to describe mixed affect
Understanding Affective Understanding Affective DisordersDisorders
Kraepelin proposed Kraepelin proposed affect to consist of 3 affect to consist of 3 componentscomponents VolitionVolition
Energy & DriveEnergy & Drive
EmotionEmotion Happy / SadHappy / Sad
IntellectIntellect Rate of thoughtsRate of thoughts Content of thoughtsContent of thoughts
Celebrities with Bipolar DisorderCelebrities with Bipolar Disorder
Kay Jamison, PhD
Margot Kidder
Ted Turner
Axl RoseJean-Claude Van Damme
Ben Stiller
Sylvia Plath
Affect - Affection
Volition – the drive to care for our offspring
Emotion – the love for our children
Intellect – the thoughts & speech related to our interactions with family and loved ones
Normal Affect
Volition
Emotion
Intellect
- Moods and disposition fluctuate over time
VolitionEmotion
Intellect
Depression
5
0
10
Mania
Volition
Emotion
Intellect
Volition
Emotion
Intellect
Mixed Affect
Wilhelm GreisingerWilhelm Greisinger MittelformenMittelformen
In which a change from In which a change from depression to manic exaltation depression to manic exaltation occurs.occurs.
““Melancholia with destructive Melancholia with destructive drives”drives”
““Melancholia with long lasting Melancholia with long lasting exaltation of volition”exaltation of volition”
In their mild forms, mittleformen In their mild forms, mittleformen are indistinguishable from are indistinguishable from personality deviations.personality deviations.
1817 - 1868
Epidemiology of Bipolar DisorderEpidemiology of Bipolar Disorder
ECA study lifetime prevalence ECA study lifetime prevalence 1.3%1.3% Bipolar I Bipolar I 0.8% 0.8% Bipolar II Bipolar II 0.5% 0.5%
Including “bipolar spectrum” disorders Including “bipolar spectrum” disorders BP Not otherwise specified BP Not otherwise specified ~3%~3%
No male or female predominance No male or female predominance Females with more depressionFemales with more depression
ECA study = Epidemiological Catchment Area survey. Bebbington P, Ramana R. Soc Psychiatry Psychiatr Epidemiol. 1995;30:279-292. Dunner DL. Bipolar Disord. 2003;5:456-463; Lish JD et al. J Affect Disord. 1994;31:281-29.
BP Disorder & GeneticsBP Disorder & Genetics
BP disorder is 80% geneticsBP disorder is 80% genetics - And 100% environmental!- And 100% environmental!
Having a BP sibling or parent increases Having a BP sibling or parent increases likelihood of developing BP likelihood of developing BP fivefoldfivefold compared compared to general population.to general population. Risk increases with increasing number of affected in Risk increases with increasing number of affected in
family.family. Overlap with genetic risk for other mood, Overlap with genetic risk for other mood,
anxiety, and psychotic disorders.anxiety, and psychotic disorders.
Spectrum of Bipolar Spectrum of Bipolar DisordersDisorders
Bipolar IBipolar I Bipolar IIBipolar II Major depression with a strong family history of Major depression with a strong family history of
bipolar disorderbipolar disorder HypomaniaHypomania Antidepressant-induced mania and hypomaniaAntidepressant-induced mania and hypomania CyclothymiaCyclothymia Rapidly changing mood swingsRapidly changing mood swings NOSNOS Secondary mania, due to other illnesses or drugsSecondary mania, due to other illnesses or drugs
Adapted from American Psychiatric Association. Practice Guideline for the Treatment of Patients with Bipolar Disorder. 2nd ed. Washington, DC; 2002.
Bipolar DisordersBipolar Disorders
Stahl SM. Essential Psychopharmacology. New York, NY: Cambridge University Press; 2000.
SUBSYNDROMAL DEPRESSION
NORMALMOOD
HYPOMANIA*
MIXED EPISODE†
MANIA
*Hypomania is a milder form of mania with similar yet less severe symptoms and less overall impairment.
†Mixed Episode is an episode that simultaneously presents symptoms of both depression and mania.
DEPRESSION
Misdiagnosis of Bipolar DisorderMisdiagnosis of Bipolar Disorder
Often mistaken for depression (40%Often mistaken for depression (40%––70% 70% initially misdiagnosed)initially misdiagnosed)1-31-3
Often see several clinicians without Often see several clinicians without accurate diagnosisaccurate diagnosis22
Mean time to diagnosis long (8 yearsMean time to diagnosis long (8 yearsin 1 study)in 1 study)3,43,4
Rate of misdiagnosis worse with Rate of misdiagnosis worse with comorbiditycomorbidity22
1. Bowden CL. J Affect Disord. 2005:84:117-125; 2. Thomas P. J Affect Disord. 2004;79(Suppl 1):S3-S8; 3. Baldessarini R et al. Am J Psychiatry. 1999;156:811-812; 4. Tondo L et al. Am J Psychiatry. 1998;155:638-645.
Misdiagnosis of Bipolar DisorderMisdiagnosis of Bipolar Disorder 2000 NDMDA initial diagnosis (69%)2000 NDMDA initial diagnosis (69%)
NDMDA = National Depressive and Manic-Depressive Association; N = 400NDMDA = National Depressive and Manic-Depressive Association; N = 400
Hirschfeld RM, et al. Hirschfeld RM, et al. J Clin PsychiatryJ Clin Psychiatry. 2004;65(suppl 15):5-9.. 2004;65(suppl 15):5-9.
60
26
18 1714
0
10
20
30
40
50
60
Depression
Anxiety
Schizophrenia
Cluster B
Alcohol abuse
Per
cen
t
Onset of Bipolar DisorderOnset of Bipolar Disorder
Onset in teens for most patientsOnset in teens for most patients(peak ages, 15(peak ages, 15––19 years) 19 years)
Late onset less rare than was thought Late onset less rare than was thought (possibly 6% aged >60 years)(possibly 6% aged >60 years)
Relapse frequent (75%Relapse frequent (75%––90%)90%)
Bebbington P, Ramana R. Soc Psychiatry Psychiatr Epidemiol. 1995;30:279-292; Sajatovic M et al. Am J Geriatr Psychiatry. 2005;13:282-289; Gitlin MJ et al. Am J Psychiatry. 1995;152:1635-1640.
McLean Harvard First-Episode McLean Harvard First-Episode Mania studyMania study
239 BP with first Manic/mixed episode239 BP with first Manic/mixed episode 173 recruited for study173 recruited for study
151 followed for an average of 4.86 years151 followed for an average of 4.86 years
Recovery at 2 yearsRecovery at 2 years Syndromal (DSMIV)98%Syndromal (DSMIV)98% Symptomatic (YM) 72%Symptomatic (YM) 72% Functional (occupational) 43%Functional (occupational) 43%
Disability With Bipolar DisorderDisability With Bipolar Disorder
Bipolar disorder is the 6th leading cause of Bipolar disorder is the 6th leading cause of medical disability worldwide among people medical disability worldwide among people aged 15 to 44 years aged 15 to 44 years
Bipolar disorder is associated with a Bipolar disorder is associated with a greater degree of disability than greater degree of disability than osteoarthritis, human immunodeficiency osteoarthritis, human immunodeficiency virus infection, diabetes, and asthmavirus infection, diabetes, and asthma
Murray CJ, Lopez AD. Lancet. 1997;349:1436-1442.
Social Impact of Bipolar DisorderSocial Impact of Bipolar Disorder
Unemployment rate 60%, includes Unemployment rate 60%, includes college graduatescollege graduates
65% report impaired long-term 65% report impaired long-term relationshipsrelationships
Hirschfeld MA et al. J Clin Psychiatry. 2003;64:161-17; Kupfer DJ et al. J Clin Psychiatry. 2002;63:120-125.
Economic Impact of Bipolar DisorderEconomic Impact of Bipolar Disorder
The estimated annual societal cost of The estimated annual societal cost of bipolar disorder ranges from $10 billion to bipolar disorder ranges from $10 billion to $45 billion$45 billion
Indirect costsIndirect costs 49.5 lost workdays/year/patient49.5 lost workdays/year/patient 180 million lost workdays/year 180 million lost workdays/year $25.9 billion salary-equivalent lost/year$25.9 billion salary-equivalent lost/year
Wyatt RJ, Henter I. Soc Psychiatry Psychiatr Epidemiol. 1995;30:213-219; Greenberg PE et al. J Clin Psychiatry. 1993;54:405-418. Begley CE et al. Pharmacoeconomics. 2001;19:483-495.
Epidemiological Catchment Area Survey Epidemiological Catchment Area Survey (ECA): Comorbidity and Bipolar Disorder(ECA): Comorbidity and Bipolar Disorder
Regier DA et al. JAMA. 1990;264:2511-2518; Chen YW, Dilsaver SC. Am J Psychiatry. 1995;152:280-282; Chen YW, Dilsaver SC. Psychiatry Res. 1995;59:57-64.
% P
atie
nts
Alcohol-use
Disorder
Substance-use
Disorder
PanicDisorder
OCD
13.5
46.2
6.1
40.7
0.8
20.8
2.6
21
0
10
20
30
40
50
General Population
Bipolar Disorder
Substance-Use Disorder & BPDSubstance-Use Disorder & BPD
Bipolar disorder with co-existing substance-use Bipolar disorder with co-existing substance-use disorder is associated with an increase in disorder is associated with an increase in Suicide attemptsSuicide attempts Suicidal ideasSuicidal ideas Seeking hospital admissionSeeking hospital admission Hospital admissionHospital admission ViolenceViolence Aggressive behaviorAggressive behavior Doubled risk of suicideDoubled risk of suicide
Potash JB et al. Am J Psychiatry. 2000;157:2048-2050; Scott H et al. Br J Psychiatry. 1998;172:345-350; Comtois KA et al. Biol Psychiatry. 2004;56:757-763; Strakowski SM, DelBello MP. Clin Psychol Rev. 2000;20:191-206; Strakowski SM et al. Arch Gen Psychiatry. 2005;62:851-858.
Substance-Use in BPD: Treatment IssuesSubstance-Use in BPD: Treatment Issues
Less likely to respond to treatmentLess likely to respond to treatment11
Less likely to adhere to medicationsLess likely to adhere to medications1,21,2
Less likely to adhere to lithium treatmentLess likely to adhere to lithium treatment
Less likely to gain full remission and Less likely to gain full remission and resolve symptoms resolve symptoms
Remission during hospitalization less likely Remission during hospitalization less likely to occur vs no substance-use disorder to occur vs no substance-use disorder
1. Goldberg JF et al. J Clin Psychiatry. 1999;60:733-740; 2. Aagaard J, Vestergaard P. J Affect Disord. 1989;12:259–266; 3. Strakowski SM et al. Arch Gen Psychiatry. 1998;55:49-55.
APA Treatment Guidelines for Comorbid APA Treatment Guidelines for Comorbid BPD and Substance-Use DisorderBPD and Substance-Use Disorder
Treatment should proceed concurrently, Treatment should proceed concurrently, preferably in a dual-diagnosis programpreferably in a dual-diagnosis program
Alcohol abuse may affect bipolar Alcohol abuse may affect bipolar pharmacotherapypharmacotherapy Alcohol-related dehydration may raise serum Alcohol-related dehydration may raise serum
lithium to toxic levelslithium to toxic levels Hepatic dysfunction may alter plasma levels Hepatic dysfunction may alter plasma levels
of valproate and carbamazepineof valproate and carbamazepine
American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Available at: http://www.psych.org/psych_pract/treatg/pg/Practice%20Guidelines8904/BipolarDisorder_2e.pdf. Accessed January 24, 2006.
Medical Conditions & BP Medical Conditions & BP
MigraineMigraine Thyroid diseaseThyroid disease
LithiumLithium Type 2 diabetesType 2 diabetes
AntipsychoticsAntipsychotics Obesity Obesity
Mood stabilizersMood stabilizers AntipsychoticsAntipsychotics
Polycystic Ovarian SyndromePolycystic Ovarian Syndrome Valproate and other anticonvulsantsValproate and other anticonvulsants
Multiple sclerosisMultiple sclerosis Multiple episodes may increase risk of dementiaMultiple episodes may increase risk of dementia
Causes of Medical Problems Causes of Medical Problems in Bipolar Disorder in Bipolar Disorder
Poor dietPoor diet SmokingSmoking11
Obesity (32%)Obesity (32%)22
MedicationsMedications InactivityInactivity
Underutilization of medical resourcesUnderutilization of medical resources Nonadherence (>50%)Nonadherence (>50%)33
1. Breslau N et al. Psychological Medicine. 2004;34:323-333; 2. Fagiolini A et al. J Clin Psychiatry. 2002;63:528-533;3. Fleck DE. J Clin Psychiatry. 2005;66:646-652; 4. Dailey LF et al. J Clin Psychiatr. 2005;66:477-484.
Obesity in Bipolar DisorderObesity in Bipolar Disorder
35.4% of patients with bipolar disorder had BMI 35.4% of patients with bipolar disorder had BMI ≥≥30 mg/kg30 mg/kg2 2
Decreased sense of well being and QOLDecreased sense of well being and QOL22
Increased relapses of depressive episodesIncreased relapses of depressive episodes2,32,3 More likely to have made a suicide attemptMore likely to have made a suicide attempt44
Bipolar disorder treatments have been Bipolar disorder treatments have been associated with weight gain and endocrine associated with weight gain and endocrine changes; new weight gain increases IR and may changes; new weight gain increases IR and may promote PCOS in predisposed womenpromote PCOS in predisposed women55
IR = insulin resistance; PCOS = polycystic ovarian syndrome.1. Fagliolini A et al. Am J Psychiatry. 2003;160:112-117; 2. McLaren KD, Marangel LB. Ann Gen Hosp Psychiatry.2004;3:7-17; 3. Post RM. J Clin Psychiatry. 2005;66(Suppl 5):5-10; 4. Osby U et al. Arch Gen Psychiatry. 2001;58:884-850; 5. Rasgon NL et al. Bipolar Disord. 2005;7:246-259.
Treatment Decisions: Bipolar Treatment Decisions: Bipolar DisorderDisorder
Selection of Initial Intervention
Sequential Care Most Benign
Urgent Care Most Effective
MonotherapyStart LowGo Slow
Combination TherapyAggressive Titration
toEffective Dose Range
Sachs GS. Managing Bipolar Affective Disorder. Science Press Ltd: London, UK; 2004.
Guidelines for Acute ManiaGuidelines for Acute Mania
Fountoulakis KN, et al. J Affect Disord. 2005;86:1-10.
Keck PE Jr, et al. Postgrad Med Special Report. 2004:1-120.
American American Psychiatric Psychiatric
Association, Association, 19941994
American American Psychiatric Psychiatric
Association, 2002Association, 2002
Expert Expert Consensus Consensus Guidelines, Guidelines,
20042004
11stst ChoiceChoice
LiLi SevereSevere: Li or Vp+AP: Li or Vp+APMild-ModMild-Mod: Li, Vp, Olz: Li, Vp, Olz
Li, Vp, OlzLi, Vp, Olz
22ndnd ChoiceChoice
Vp, CbzVp, CbzAPs only for the APs only for the rapid control of rapid control of agitationagitation
Various Various combinations of two combinations of two 11stst choice agents choice agents ECTECT
Cbz, Risp, Cbz, Risp, QuetQuet
AP = antipsychotic; Cbz = carbamazapine; ECT = electroconvulsive therapy; Li = lithium; Olz = olanzapine; Quet = quetiapine; Risp = risperidone; Vp = valproate.
Guidelines for Acute Bipolar Guidelines for Acute Bipolar DepressionDepression
Fountoulakis KN, et al. J Affect Disord. 2005;86:1-10.
Keck PE Jr, et al. Postgrad Med Special Report. 2004:1-120.
American American Psychiatric Psychiatric
Association, Association, 19941994
American American Psychiatric Psychiatric
Association, 2002Association, 2002
Expert Expert Consensus Consensus Guidelines, Guidelines,
20042004
11stst ChoiceChoice
LiLi Li or La or Li+ADLi or La or Li+ADECTECT
Li, LaLi, La
22ndnd ChoiceChoice
Vp, CbzVp, CbzECTECTAD are AD are considered to considered to worsen the long-worsen the long-term course of term course of the illnessthe illness
Combination of 1Combination of 1stst choice agentschoice agentsECTECT
Li or La, or Li or La, or Li+AD,Li+AD,Quet, RispQuet, Risp
AD = antidepressant; Cbz = carbamazapine; ECT = electroconvulsive therapy; La = lamotrigine; Li = lithium; Olz = olanzapine; Quet = quetiapine; Risp = risperidone; Vp = valproate.
Guidelines for Bipolar Guidelines for Bipolar MaintenanceMaintenance
Fountoulakis KN, et al. J Affect Disord. 2005;86:1-10.
Keck PE Jr, et al. Postgrad Med Special Report. 2004:1-120.
American American Psychiatric Psychiatric
Association, Association, 19941994
American American Psychiatric Psychiatric
Association, 2002Association, 2002
Expert Expert Consensus Consensus Guidelines, Guidelines,
20042004
11stst ChoiceChoice
Continue the Continue the treatment proved treatment proved efficient during efficient during the acute phasethe acute phase
Li or Vp possibly Li or Vp possibly Cbz, La, OCbzCbz, La, OCbzContinue the Continue the treatmenttreatment
Li, Vp, OlzLi, Vp, Olz
22ndnd ChoiceChoice
ECTECT
Combination of Combination of 11stst choice agents choice agents
ECTECT
Combination of 1Combination of 1stst choice agentschoice agentsAP should be AP should be discontinueddiscontinued
Cbz, Risp, Cbz, Risp, Quet, Arip, Quet, Arip, ZiprZipr
Arip = aripiprazole; Cbz = carbamazapine; ECT = electroconvulsive therapy; La = lamotrigine; Li = lithium; OCBz = oxcarbamazepine; Olz = olanzapine; Quet = quetiapine; Risp = risperidone; Vp = valproate; Zipr = ziprasidone.
Suicide Risk in Bipolar DisorderSuicide Risk in Bipolar Disorder
Patients with bipolar disorder have a higher Patients with bipolar disorder have a higher risk of suicide than patients with any other risk of suicide than patients with any other psychiatric or medical illnesspsychiatric or medical illness
Odds ratio for suicide attempts is 6.2, higher Odds ratio for suicide attempts is 6.2, higher than any other disorder, including depressionthan any other disorder, including depression
Woods SW. J Clin Psychiatry. 2000;61(Suppl 13):38-41; Chen YW, Dilsaver SC. Biol Psychiatry. 1996;39:896-899;Goldberg JF, Harrow M. J Affect Disord. 2004;81:123-131.
Sta
nd
ard
ized
Mo
rtal
ity
Rat
io*
Increased Mortality in Patients Increased Mortality in Patients With Bipolar DisorderWith Bipolar Disorder
*SMR = standardized mortality ratio: observed events ÷ expected events; †Unnatural = accidents, suicide, homicide, undetermined deaths.GI = gastrointestinal.Osby U et al. Arch Gen Psychiatry. 2001;58:884-850.
All Causes
CVD GI Unnatural†Cerebro-vascular
Cancer
2.5 2.71.9
2.6
1.1 1.21.9 2 2 1.9
8.6
12.7
0
2
4
6
8
10
12
14
Males (n=6578)Females (n=8808)
Suicide prevention and Suicide prevention and LithiumLithium
In a meta-analysis of 22studies – the computed risk-ratio for on vs off lithiumwas 8.85
Tondo et al, 2001 Acta Psych Scand
BP Concluding statements..BP Concluding statements..
Bipolar Disorders are a category of mood Bipolar Disorders are a category of mood disorders - with a broad range of severity.disorders - with a broad range of severity.
BP is eminently treatable.BP is eminently treatable. But requires treatment to be ongoing But requires treatment to be ongoing
Collaboration between Treatment team and patientCollaboration between Treatment team and patient BP is a serious illness.BP is a serious illness.
Lives, families, and careers affectedLives, families, and careers affected People die from itPeople die from it
Prechter Bipolar Genes ProjectPrechter Bipolar Genes Project
GoalsGoals Determine what keeps BP patients well, and Determine what keeps BP patients well, and
what causes problemswhat causes problems Find the genes involvedFind the genes involved
StudyStudy Track participants for 5 years through Track participants for 5 years through
interview, questionnaires, cognitive testinginterview, questionnaires, cognitive testing Collect blood sample for DNA analysisCollect blood sample for DNA analysis
Prechter Bipolar Genes ProjectPrechter Bipolar Genes Project
For more information:For more information: www.hcpfmd.orgwww.hcpfmd.org www.depressioncenter.orgwww.depressioncenter.org
New toll-free #:New toll-free #: 1-877-UM GENES1-877-UM GENES (1-877-864 3637)(1-877-864 3637) Email: Email:
[email protected]@umich.edu
Panel MembersPanel Members Melvin McInnis, MDMelvin McInnis, MD
University of MichiganUniversity of Michigan Cheryl King, PhDCheryl King, PhD
University of MichiganUniversity of Michigan Juan Lopez, MDJuan Lopez, MD
University of MichiganUniversity of Michigan Shabnum H. Sheikh, MDShabnum H. Sheikh, MD
St Joseph Mercy HospitalSt Joseph Mercy Hospital Jon-Kar Zubieta, MDJon-Kar Zubieta, MD
University of MichiganUniversity of Michigan Katharene Schoof, MSW, ACSW Katharene Schoof, MSW, ACSW
University of MichiganUniversity of Michigan